![]() |
|
|
Vol. 287, Issue 2, 598-605, November 1998
Department of Pharmacology and Toxicology, Medical College of
Virginia, Virginia Commonwealth University (M.D.A., S.M.S., B.R.M.),
Richmond, Virginia and
Organix, Inc. (R.K.R.), Woburn, Massachusetts
Using
N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxamide
· HCl (SR 141716A), a cannabinoid antagonist, several investigators
(; ,
; ) demonstrated physical dependence on
THC [
9-tetrahydrocannabinol]. This demonstration
prompted us to determine whether anandamide, an endogenous cannabinoid
agonist, would also produce physical dependence. A low-dose regimen
(10, 20, 40 and 40) or a high-dose regimen (25, 50, 100 and 100)
expressed as mg/kg/24 hr was infused i.p. on a continuous basis, from
days 1 through 4, respectively. During the infusion, especially at the
high-dose regimen, the rats became immobile and developed eyelid
ptosis. Abrupt discontinuation of anandamide did not elicit rebound
behavioral activity. Neither arachidonic acid, a precursor and
metabolite of anandamide (50, 100, 200 and 200 mg/kg/24 hr on days 1 through 4, respectively), nor 2-Me-F-AN
[2-methylarachidonyl-(2'-fluoroethyl)-amide], a metabolically stable
analog of anandamide (5, 10, 20 and 20 mg/kg/24 hr for 4 days,
respectively), had remarkable effects. Notably, groups pretreated with
anandamide or 2-Me-F-AN and challenged with SR 141716A did not show
significantly elevated behavioral scores when compared with SR 141716A
controls. On the other hand, nearly all groups receiving SR 141716A
showed significant activation of these behaviors compared with vehicle
controls, which suggests that this cannabinoid antagonist itself was
activating behavior. We concluded that anandamide has little if any
capacity for physical dependence. The finding that SR 141716A activated
behavior supports the hypothesis that the cannabimimetic system exerts
a depressant effect in the CNS.
This article has been cited by other articles:
![]() |
Z. Justinova, M. Solinas, G. Tanda, G. H. Redhi, and S. R. Goldberg The Endogenous Cannabinoid Anandamide and Its Synthetic Analog R(+)-Methanandamide Are Intravenously Self-Administered by Squirrel Monkeys J. Neurosci., June 8, 2005; 25(23): 5645 - 5650. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fedorova, A. Hashimoto, R. A. Fecik, M. P. Hedrick, L. O. Hanus, D. L. Boger, K. C. Rice, and A. S. Basile Behavioral Evidence for the Interaction of Oleamide with Multiple Neurotransmitter Systems J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 332 - 342. [Abstract] [Full Text] [PDF] |
||||